SYNGENE Trademark
SYNGENE is a USPTO trademark filed by CYTOGEN CORPORATION. Status: Abandoned.
Prosecution Summary
Trademark Summary
The SYNGENE standard character mark covers genes for manufacturing pharmaceutical preparations for therapeutic or diagnostic purposes (Class 001), pharmaceutical preparations for diagnosis and treatment of inflammatory, immuno-regulatory, cardiovascular, neurological diseases, and cancer (Class 005), and gene research and design for medical purposes (Class 042). It is owned by CYTOGEN CORPORATION, a Delaware corporation based in Princeton, New Jersey. The application reached published for opposition status but is now abandoned because no Statement of Use or Extension Request was timely filed after the Notice of Allowance.
Recent Activity
Filed on September 28, 1994, the mark was published for opposition on November 21, 1995, and received a Not
Trademark Facts
| Mark | SYNGENE |
|---|---|
| Serial Number | 74579509 |
| Status | Abandoned |
| Filing Date | 1994-09-28 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals), 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | CYTOGEN CORPORATION |
| Attorney of Record | William G. Pecau |
| Prosecution Events | 15 |
| Latest Event | ABN6 on 1998-02-14 |
Goods & Services
pharmaceutical preparations for therapeutic or diagnostic purposes, namely diagnosis and treatment of inflammatory, immuno-regulatory, cardiovascular and neurological diseases, and cancer; genes for the manufacture of pharmaceutical preparations for therapeutic or diagnostic purposes; gene research, and design of genes for medical purposes